Background
Escherichia coli can play either a commensal or parasitic relationship with humans, with the latter leading to intestinal or extra-intestinal (EI) infections [1] . Whereas commensal E. coli strains represent predominantly (low-virulence) phylogenetic groups A and B1, strains causing EI infections (which are known as ExPEC -Extraintestinal Pathogenic E. coli) have been shown to correlate to the high-virulence phylogroups B2 and D [1, 2] . However, E. coli strains exhibiting low-virulence backgrounds, such as the commensal strains, have been isolated under pathogenic conditions [1, 3] , indicating that pathogenic commensals can cause EI infections when the bacterium gains access to a normally sterile body site, mainly in patients with susceptibility linked to underlying disease [1, 3] .
In hospital settings, the treatment of E. coli infections has been hindered by the emergence of antibiotic-resistant strains, with extended-spectrum β-lactamase (ESBL) production being of particular concern, because third-generation cephalosporins are the drugs of choice for the treatment of ExPEC [4] .
In Brazil, there is a paucity of studies on phylogenetic analysis of commensal and pathogenic ESBL-producing E. coli. The aim of this study, therefore, was to characterize the extended-spectrum β-lactamase (ESBL) production, phylogenetic backgrounds, and the clonal relationship among E. coli strains isolated from EI infections in inpatients and outpatients admitted in a university hospital, in São Paulo, Southeastern Brazil.
The Study
From January 2005 to July 2007, a total of 34 E. coli strains exhibiting an ESBL phenotype were isolated from clinical samples obtained from 28 patients with EI in a single secondary care teaching hospital in São Paulo, Brazil. Antimicrobial susceptibility profiles were determined by Kirby-Bauer disk diffusion method [5] , and ESBL production was investigated by using a double-disc synergy test and Etest ESBL strips (bioMeriéux, Marcy-l'Etoile, France). DNA amplification by PCR was used to search for bla CTX-M -, bla TEM -, bla SHV -, bla GES -and bla PER -type ESBL genes [6] , whereas phylogenetic typing (A, B1, B2 and D) was performed by means of a multiplex PCR reaction with phylogenetic markers, chuA, yjaA, and TspE4.C2 [2] . The genetic relatedness of the isolates was determined by PFGE of XbaI-digested genomic DNA using the protocol proposed by the National Molecular Subtyping Network (http://www.cdc.gov/pulsenet/protocols/ecoli_salmone lla_shigella_protocols.pdf), and multilocus sequence typing (MLST) analysis was performed to characterize the genotype of CTX-M-15-producing E. coli (http://mlst.ucc.ie/mlst/dbs/Ecoli). PFGE patterns were analyzed using the Dice similarity coefficient and the unweighted-pair group method using average linkages cluster method (BioNumerics software, Applied Maths, Kortrijk, Belgium). PFGE clusters I to XXXI were assigned based on less than 90% similarity of banding patterns.
ESBL-positive E. coli strains, isolated mainly from urinary tract infections (56%), exhibited resistance to ampicillin (100%), cephalothin (100%), ceftriaxone (100%), cefotaxime (100%), ceftazidime (79%), cefepime (94%), ciprofloxacin (50%), sulfamethoxazole/trimethoprim (62%), gentamicin (56%) and amikacin (6%), remaining susceptible to imipenem (100%). All strains carried bla CTX-M -type genes, with bla CTX-M-2 being the most prevalent variant (n = 32), whereas the genes bla CTX-M- 15 and bla CTX-M-1 were only found in one strain of E. coli (Table 1) .
XbaI PFGE analysis revealed the presence of 31 PFGE types among CTX-M producers (named clusters I to XXXI) (Figure 1) , and phylogenetic investigation showed that low-virulence phylogenetic groups A (18%) and B1 (52%) were predominant over highvirulence phylogenetic groups B2 (12%) and D (18%). Correlation between ESBL genotype and phylogenetic group revealed that of 18 E. coli isolates belonging to phylogenetic group B1, 16 isolates carried the bla CTX-M-2 gene, whereas another two strains harbored the bla CTX-M-1 and bla CTX-M-15 genes, respectively (Table 1, Figure 1 ). The CTX-M-15-producing ExPEC belonged to the international sequence type ST648. In urinary tract infections, CTX-M-producing E. coli represented predominantly low-virulence phylogenetic group B1 (57.9%). Strains obtained from a same patient were identified by using superscript lowercase letters "a" to "e". (9) 4 (12) 4 (12) 4 (12) 4 (12) 3 (9) 4 (12) 1 (3) 2 (6) The results of the present study show that dissemination of bla CTX-M genes (mainly bla CTX-M-2 ) is the leading cause of resistance to β-lactam antibiotics in E. coli strains isolated in the university hospital studied, whereas PFGE analysis revealed that the strains encompass a great genetic diversity, with the 34 strains presenting 31 different profiles (Figure 1) , which is indicative of probable infection by E. coli strains of commensal origin. In fact, in this study, lowvirulence phylogenetic groups B1 and A were predominant over high-virulence phylogenetic groups B2 and D (Table 1) . Phylogenetic analyses have shown that E. coli strains fall into four main phylogenetic groups (A, B1, B2, and D), and that virulent extra-intestinal strains belong mainly to group B2 and, to a lesser extent, to group D, whereas most commensal strains belong to A and B1 groups [1, 2] . Therefore, most likely the widespread use of antibiotics in Brazil may be contributing to the selection of silent carriers of resistance genes among commensal strains. In fact, a study conducted in remote communities from the Brazilian Amazon region revealed that commensal E. coli from healthy children showed high levels of multidrug resistance [7] . Similar results were reported from Bolivian and Peruvian communities [8] , where the identification of CTX-M ESBLs in E. coli from healthy children have been identified as a serious emerging threat [9] . CTX-M beta-lactamases had been widely distributed in South America at least since 1989, and possibly before appearing in Europe. After a period of CTX-M-2 prevalence, new CTX-M variants started to be progressively reported worldwide, with the international CTX-M-15-producing E. coli clone O25-ST131 representing a major public health problem [10] . In Brazil, only a few MLST studies of ESBLproducing E. coli have been published [11, 12] . In these studies, while predominance of ST410 (CC23) was observed among CTX-M-15-producing E. coli strains belonging to phylogroup A, MLST analysis indicated high genetic diversity among CTX-M-2-producing E. coli strains in the Southeast region of Brazil [11, 12] . In this study, we report further data on the identification of CTX-M-15-producing ExPEC belonging to the international sequence type ST648. ST648 with CTX-M-15 has previously been described in clinical isolates from USA [13] , China [14] , Netherlands [15] , Canada [16] , Korea [17] and Tanzania [18] .
Conclusion
The spread of bla CTX-M genes is the main problem associated with resistance to cephalosporins in clinical isolates of E. coli at the university hospital studied. One finding of interest is the identification of CTX-M-15-producing E. coli belonging to the international sequence type ST648, which had not previously been reported in this region. The predominance of lowvirulence phylogenetic groups A and B1 among CTX-M-producing ExPEC strains suggests that, in this study, most EI infections caused by ESBL-producing E. coli are endogenous, probably resulting from infection with strains of commensal origin that can play key roles as reservoirs of antibiotic resistance genes and as drug-resistant pathogens, which is a worrisome prospect, given that E. coli is ubiquitous among humans and other animals that can serve as hosts.
